Jin et al. proved that miR-654 was identified as a target of circHIPK3 while miR-654 targeted IGF2BP3, circHIPK3 promoted glioma progression through the circHIPK3/miR-654/IGF2BP3 network [50]. The gene discussed is IGF2BP3; the disease is central nervous system cancer.